HWM
HighMark Wealth Management Portfolio holdings
AUM
$205M
1-Year Return
18.44%
This Quarter Return
+15.41%
1 Year Return
+18.44%
3 Year Return
+65.97%
5 Year Return
+111.28%
10 Year Return
–
AUM
$116M
AUM Growth
+$5.39M
(+4.9%)
Cap. Flow
-$8.84M
Cap. Flow
% of AUM
-7.6%
Top 10 Holdings %
Top 10 Hldgs %
76.97%
Holding
502
New
44
Increased
111
Reduced
97
Closed
48
Top Buys
| 1 |
iShares MSCI EAFE Value ETF
EFV
|
$410K |
| 2 |
iShares TIPS Bond ETF
TIP
|
$242K |
| 3 |
SPDR Portfolio Emerging Markets ETF
SPEM
|
$218K |
| 4 |
iShares S&P Mid-Cap 400 Value ETF
IJJ
|
$206K |
| 5 |
iShares S&P 500 Value ETF
IVE
|
$202K |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$6.74M |
| 2 |
CareDx
CDNA
|
$346K |
| 3 |
SI-BONE Inc
SIBN
|
$292K |
| 4 |
Microsoft
MSFT
|
$264K |
| 5 |
Halozyme
HALO
|
$229K |
Sector Composition
| 1 | Healthcare | 11.54% |
| 2 | Technology | 2.21% |
| 3 | Financials | 2.2% |
| 4 | Industrials | 1.68% |
| 5 | Consumer Discretionary | 1.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Schwab US Broad Market ETF
SCHB
$36.3B
| $25K | 0.02% |
1,668
+6
| +0.4% | +$90 |
|
152
Schwab US Large- Cap ETF
SCHX
$59.2B
| $25K | 0.02% |
1,626
+6
| +0.4% | +$92 |
|
153
Steris
STE
$24.2B
| $25K | 0.02% |
131
| – | – |
|
|
B
154
Barrick Mining Corporation
B
$48.5B
| $24K | 0.02% |
1,041
+3
| +0.3% | +$69 |
|
155
Walmart
WMT
$801B
| $24K | 0.02% |
510
-36
| -7% | -$1.69K |
|
156
Etsy
ETSY
$5.36B
| $23K | 0.02% |
+132
| New | +$23K |
|
|
NCZ
157
Virtus Convertible & Income Fund II
NCZ
$259M
| $23K | 0.02% |
1,113
| – | – |
|
158
Thermo Fisher Scientific
TMO
$186B
| $22K | 0.02% |
47
+6
| +15% | +$2.81K |
|
159
iShares US Healthcare ETF
IYH
$2.77B
| $21K | 0.02% |
435
-30
| -6% | -$1.45K |
|
160
Axogen
AXGN
$735M
| $21K | 0.02% |
1,167
-5,808
| -83% | -$105K |
|
161
Diageo
DEO
$61.3B
| $21K | 0.02% |
132
+1
| +0.8% | +$159 |
|
162
FedEx
FDX
$53.7B
| $20K | 0.02% |
78
-105
| -57% | -$26.9K |
|
163
Stryker
SYK
$150B
| $20K | 0.02% |
81
| – | – |
|
|
ARNA
164
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $20K | 0.02% |
260
-708
| -73% | -$54.5K |
|
|
FPRX
165
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $20K | 0.02% |
+1,189
| New | +$20K |
|
166
UnitedHealth
UNH
$286B
| $19K | 0.02% |
55
+21
| +62% | +$7.26K |
|
167
Y-mAbs Therapeutics
YMAB
$390M
| $19K | 0.02% |
381
-1,899
| -83% | -$94.7K |
|
168
Bank of America
BAC
$369B
| $18K | 0.02% |
583
| – | – |
|
169
iShares Core High Dividend ETF
HDV
$11.5B
| $18K | 0.02% |
208
-122
| -37% | -$10.6K |
|
170
Idexx Laboratories
IDXX
$51.4B
| $18K | 0.02% |
36
-1
| -3% | -$500 |
|
171
Teradyne
TER
$19.1B
| $18K | 0.02% |
153
| – | – |
|
172
Zymeworks
ZYME
$1.14B
| $18K | 0.02% |
386
-1,256
| -76% | -$58.6K |
|
173
Alibaba
BABA
$323B
| $17K | 0.01% |
72
-28
| -28% | -$6.61K |
|
174
Kinross Gold
KGC
$26.9B
| $17K | 0.01% |
2,275
+13
| +0.6% | +$97 |
|
175
NeoGenomics
NEO
$1.03B
| $17K | 0.01% |
316
-1,933
| -86% | -$104K |
|